ResMed, Inc. (RMD)
234.58
-2.01
(-0.85%)
USD |
NYSE |
Aug 26, 09:47
ResMed EPS Diluted (Quarterly) : 2.645 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.645 |
| March 31, 2026 | 2.736 |
| December 31, 2025 | 2.682 |
| September 30, 2025 | 2.373 |
| June 30, 2025 | 2.582 |
| March 31, 2025 | 2.480 |
| December 31, 2024 | 2.337 |
| September 30, 2024 | 2.110 |
| June 30, 2024 | 1.981 |
| March 31, 2024 | 2.038 |
| December 31, 2023 | 1.415 |
| September 30, 2023 | 1.488 |
| June 30, 2023 | 1.556 |
| March 31, 2023 | 1.577 |
| December 31, 2022 | 1.526 |
| September 30, 2022 | 1.430 |
| June 30, 2022 | 1.327 |
| March 31, 2022 | 1.218 |
| December 31, 2021 | 1.372 |
| September 30, 2021 | 1.386 |
| June 30, 2021 | 1.331 |
| March 31, 2021 | -0.5393 |
| December 31, 2020 | 1.226 |
| September 30, 2020 | 1.221 |
| June 30, 2020 | 1.219 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.120 |
| December 31, 2019 | 1.103 |
| September 30, 2019 | 0.828 |
| June 30, 2019 | 0.4755 |
| March 31, 2019 | 0.7304 |
| December 31, 2018 | 0.86 |
| September 30, 2018 | 0.73 |
| June 30, 2018 | 0.7626 |
| March 31, 2018 | 0.76 |
| December 31, 2017 | 0.07 |
| September 30, 2017 | 0.60 |
| June 30, 2017 | 0.71 |
| March 31, 2017 | 0.62 |
| December 31, 2016 | 0.54 |
| September 30, 2016 | 0.54 |
| June 30, 2016 | 0.59 |
| March 31, 2016 | 0.64 |
| December 31, 2015 | 0.68 |
| September 30, 2015 | 0.57 |
| June 30, 2015 | 0.61 |
| March 31, 2015 | 0.64 |
| December 31, 2014 | 0.64 |
| September 30, 2014 | 0.58 |
| June 30, 2014 | 0.61 |
| March 31, 2014 | 0.63 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Koninklijke Philips NV | 0.461 |
| Accuray, Inc. | -0.0154 |
| Medtronic Plc | 0.9649 |
| Orthofix Medical, Inc. | -0.3862 |
| Rockwell Medical, Inc. | -0.3352 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 383.43M |
| Revenue (Quarterly) | 1.464B |
| Total Expenses (Quarterly) | 1.080B |
| Enterprise Value | 33.48B |
| Gross Profit Margin (Quarterly) | 58.12% |
| Profit Margin (Quarterly) | 26.20% |
| Earnings Yield | 4.45% |
| Operating Earnings Yield | 5.62% |
| Normalized Earnings Yield | 4.481 |